Interferon-β and mycophenolic acid are potent inhibitors of middle east respiratory syndrome coronavirus in cell-based assays

Journal of General Virology

Volumn 95, Issue PART3, 2014, Pages 571-577

  Hart, Brit J ^a   Dyall, Julie ^a   Postnikova, Elena ^a   Zhou, Huanying ^a   Kindrachuk, Jason ^a   Johnson, Reed F ^a   Olinger Jr , Gene G ^a   Frieman, Matthew B ^b   Holbrook, Michael R ^a   Jahrling, Peter B ^a   Hensley, Lisa ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; CORONAVIRIDAE; CORONAVIRIDAE INFECTIONS; HUMANS; INTERFERONS; MYCOPHENOLIC ACID; VERO CELLS; VIRUS REPLICATION;

EID: 84894028391     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.061911-0     Document Type: Article

References (22)

1. Barnard, D. L., Day, C. W., Bailey, K., Heiner, M., Montgomery, R., Lauridsen, L., Winslow, S., Hoopes, J., Li, J. K. & other authors (2006). Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin. Antiviral Res 71, 53-63.
2. Brown, C., Carson, G., Chand, M. & Zambon, M. for Public Health England and International Severe Acute Respiratory & Emerging Infection Consortium (2013). Treatment of MERS-CoV: decision support tool. Clinical decision making tool for the treatment of MERS-CoV v.1.1, 29 July 2013. Available at: http://isaric.tghn.org/site_media/media/articles/Decision_Support_Document_v1_1_20130729.pdf. Accessed 5 October 2013.
3. Chan, J. F., Chan, K. H., Kao, R. Y., To, K. K., Zheng, B. J., Li, C. P., Li, P. T., Dai, J., Mok, F. K. & other authors (2013a). Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus. J Infect 67, 606-616.
4. Chan, R. W., Chan, M. C., Agnihothram, S., Chan, L. L., Kuok, D. I., Fong, J. H., Guan, Y., Poon, L. L., Baric, R. S. & other authors (2013b). Tropism of and innate immune responses to the novel human betacoronavirus lineage C virus in human ex vivo respiratory organ cultures. J Virol 87, 6604-6614.
5. de Groot, R. J., Baker, S. C., Baric, R. S., Brown, C. S., Drosten, C., Enjuanes, L., Fouchier, R. A., Galiano, M., Gorbalenya, A. E. & other authors (2013). Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group. J Virol 87, 7790-7792.
6. de Wilde, A. H., Raj, V. S., Oudshoorn, D., Bestebroer, T. M., van Nieuwkoop, S., Limpens, R. W., Posthuma, C. C., van der Meer, Y., Bárcena, M. & other authors (2013). MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-α treatment. J Gen Virol 94, 1749-1760.
7. Falzarano, D., de Wit, E., Martellaro, C., Callison, J., Munster, V. J. & Feldmann, H. (2013a). Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin. Sci Rep 3, 1686.
8. Falzarano, D., de Wit, E., Rasmussen, A. L., Feldmann, F., Okumura, A., Scott, D. P., Brining, D., Bushmaker, T., Martellaro, C. & other authors (2013b). Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques. Nat Med 19, 1313-1317.
9. Henry, S. D., Metselaar, H. J., Lonsdale, R. C., Kok, A., Haagmans, B. L., Tilanus, H. W. & van der Laan, L. J. (2006). Mycophenolic acid inhibits hepatitis C virus replication and acts in synergy with cyclosporin A and interferon- α. Gastroenterology 131, 1452-1462.
10. ISARIC (2013). Clinical Decision Making Tool for Treatment of MERSCoV v.1.1 (29 July). International Severe Acute Respiratory & Emerging Infection Consortium (ISARIC). Available at: http://isaric.tghn.org/articles/pheisaric-decision-support-document/ Accessed August 5, 2013.
11. Josset, L., Textoris, J., Loriod, B., Ferraris, O., Moules, V., Lina, B., N'guyen, C., Diaz, J. J. & Rosa-Calatrava, M. (2010). Gene expression signature-based screening identifies new broadly effective influenza A antivirals. PLoS ONE 5, e13169.
12. Khan, M., Dhanwani, R., Patro, I. K., Rao, P. V. & Parida, M. M. (2011). Cellular IMPDH enzyme activity is a potential target for the inhibition of Chikungunya virus replication and virus induced apoptosis in cultured mammalian cells. Antiviral Res 89, 1-8.
13. Kindler, E., Jónsdóttir, H. R., Muth, D., Hamming, O. J., Hartmann, R., Rodriguez, R., Geffers, R., Fouchier, R. A., Drosten, C. & other authors (2013). Efficient replication of the novel human betacoronavirus EMC on primary human epithelium highlights its zoonotic potential. mBio 4, e00611.
14. Leyssen, P., Balzarini, J., De Clercq, E. & Neyts, J. (2005). The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase. J Virol 79, 1943-1947.
15. Ludwig, S. (2011). Disruption of virus-host cell interactions and cell signaling pathways as an anti-viral approach against influenza virus infections. Biol Chem 392, 837-847.
16. Morrey, J. D., Smee, D. F., Sidwell, R. W. & Tseng, C. (2002). Identification of active antiviral compounds against a New York isolate of West Nile virus. Antiviral Res 55, 107-116.
17. Pan, Q., de Ruiter, P. E., Metselaar, H. J., Kwekkeboom, J., de Jonge, J., Tilanus, H. W., Janssen, H. L. & van der Laan, L. J. (2012). Mycophenolic acid augments interferon-stimulated gene expression and inhibits hepatitis C virus infection in vitro and in vivo. Hepatology 55, 1673-1683.
18. Reed, L. J. & Muench, H. (1938). A simple method of estimating fifty per cent endpoints. Am J Epidemiol 27, 493-497.
19. Smee, D. F., Bray, M. & Huggins, J. W. (2001). Antiviral activity and mode of action studies of ribavirin and mycophenolic acid against orthopoxviruses in vitro. Antivir Chem Chemother 12, 327-335.
20. Tisoncik, J. R., Simmons, C. P., Farrar, J., Martin, T. R. & Katze, M. G. (2012). Into the eye of the cytokine storm. Microbiol Mol Biol Rev 76, 16-32.
21. World Health Organization (2013). Global Alert and Response (GAR). Middle East respiratory syndrome coronavirus (MERS-CoV) - update. Available: http://www.who.int/csr/don/2013_09_20/en/. Accessed 5 October 2013.
22. Zaki, A. M., Van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E. & Fouchier, R. A. M. (2012). Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 367, 1814-1820.